Natural clays have been used to heal skin infections since the earliest recorded history. Recently, our attention was drawn to a clinical use of French green clay (rich in Fe-smectite) for healing Buruli ulcer, a necrotizing fasciitis ('flesh-eating' infection) caused by Mycobacterium ulcerans. These clays and others like them are interesting as they may reveal an antibacterial mechanism that could provide an inexpensive treatment for this and other skin infections, especially in global areas with limited hospitals and medical resources.
Introduction
The role of clays in human health has experienced a revival in interest due to advances in modern instrumentation [e.g. transmission electron microscopy (TEM), field emission scanning electron microscopy (FESEM), atomic force microscopy (AFM), and secondary ion mass spectrometry (SIMS)], which allow us to study surfaces of nanoscale minerals in situ, within their natural environmental matrix. By identifying the special characteristics that make a particular clay antibacterial, we may elucidate some of the reasons these common nanominerals not only have potential applications in medicine, but may also contribute to the general understanding of antibacterial mechanisms, lending insights into potential cures.
Recent reviews regarding uses of clay in achieving and maintaining human health have focused on the ancient practice of geophagy, which is the practice of eating earth materials containing clay minerals (Wilson 2003; Ferrell 2008; Williams et al. 2009 ). The purpose of geophagy is to elicit a healing response in humans through ingesting the easily available materials that may physically soothe an infected and inflamed gastrointestinal lining (Droy-Lefaix and Tateo 2006) . Alternatively, clays have been used topically in mud spas (pelotherapy) to adsorb toxins from skin and provide heat to stimulate circulation for rheumatism treatment (Carretero et al. 2006; Gomes and Silva 2007) . Historical accounts of humans using 'healing clay' began with Aristotle (384-322 BC) , and Pliny the Elder (AD 23-79) later recounted the cure of intestinal ailments by ingestion of volcanic muds (Carretero et al. 2006) . Of the many historical accounts of clays, muds, and soils used by people for 'healing', the scientific evidence of the action of clays for treating and healing ulcers, tumours, cysts, cancers, osteoporosis, etc., is lacking.
Nonetheless, the observations of humans who have been 'cured' of illness by clay applications and the correlating photographic documentation (Brunet de Courssou 2002; Williams et al. 2004) were the stimuli for our research into the healing mechanism of clays. We provide a general compilation of the descriptions of healing and the common mineralogical attributes of clays and clay minerals used in the past.
In 2002, Line Brunet de Courssou reported to the World Health Organization (WHO) a summary of nearly 10 years of work in Côte d'Ivoire (west Africa), where she documented the use of specific clay minerals as therapeutic treatment of advanced Buruli ulcer disease (Brunet de Courssou 2002) . However, she was unable to conduct additional experiments of traditional and accepted scientific studies due to lack of financial support. There have been several reports describing the antibacterial properties of natural and synthetic clay minerals (Herrera et al. 2000; Wilson 2003; Williams et al. 2004; Hu et al. 2005; Tong et al. 2005; Haydel et al. 2008) . Despite these studies and the clinical evidence suggesting that clay minerals promote healing in individuals infected with Mycobacterium ulcerans, the chemical interaction occurring at the clay mineral-bacterial interface and the mechanism by which the clay minerals inhibit bacterial growth remain unknown.
Our research into the healing process led us to propose in vitro testing of the effect of 'healing clays' on a broad spectrum of human bacterial pathogens. We make an important distinction between 'healing clays' and 'antibacterial clays'. While clays may heal various ailments by their unique physical properties (e.g. high absorbance, surface area, heat capacity, exchange capacity, etc.), we have identified only a few natural clays that kill pathogenic bacteria. Building on the recent literature on healing and antibacterial minerals and compounds, this article reviews the methods and analytical protocols we have established for investigating the antibacterial properties of clays.
Traditional uses of clays for human health
Healing practices of ancient cultures, as well as modern society, have depended on clay minerals with powerful adsorptive and absorptive properties to treat a variety of topical maladies. Adsorption is the process of attraction, binding, and accumulation of molecules or particles to a solid surface in a condensed layer. Absorption results when a substance diffuses or penetrates into a liquid or solid, forming a transition zone or layer, often with a new composition, adjacent to the substrate. Clay minerals are ubiquitous in nature and their adsorptive and absorptive capabilities have been exploited in a variety of cosmetics and pharmaceutical formulations. Traditionally, clay minerals are mixed with water for various periods of time (days to years) to form clay gels or pastes that can be applied externally for cosmetic or skin protective purposes (Carretero 2002; Carretero and Lagaly 2007; Gomes and Silva 2007) . The high adsorption and absorption capacities, cation exchange capacity, as well as the extremely fine particle size of certain clays, e.g. smectites (expandable clay minerals) and kaolin group minerals, are important reasons why these minerals are used to remove oils, secretions, toxins, and contaminants from the skin. By adsorbing and absorbing moisture and impurities from the skin, the clays also serve to cleanse and refresh the skin surface and to aid in the healing of topical blemishes, the major selling point for many cosmetics. Although consumers generally consider clays to be safe when applied topically, it is important to recognize that cosmetic firms must substantiate the safety of their products and that the US Food and Drug Agency does not subject these products to pre-market approval.
The intentional consumption of earth materials, such as clays, by humans and animals is known as geophagy (Wilson 2003) . This complex and poorly understood practice is largely attributed to religious beliefs, cultural practices, psychological disorders, dietary/ nutritional needs, and medicinal benefits (Hunter 1973; Abrahams and Parsons 1996; Aufreiter et al. 1997) . Although often viewed as an abnormal behaviour by medical practitioners (i.e. pica), geophagy is believed to be an adaptive phenomenon in mammals and primates and a learned behaviour in various societal cultures (Klaus and Schmidt 1998; Krishnamani and Mahaney 2000) . Historically, geophagy is believed to be practised to remedy a physiological response to mineral nutrient deficiencies, such as those of iron or zinc, to satisfy a dietary craving, and to ease psycho-social problems, including anxiety, stress, and obsessive-compulsive disorder (Sayetta 1986; Lacey 1990) . However, several studies and medical reports indicate that ingesting large amounts of clay (>200 g per day), particularly clay with a high cation exchange capacity, can impede absorption of iron, zinc, and potassium, leading to iron, zinc, or potassium deficiencies (Mengel et al. 1964; Minnich et al. 1968; Cavdar and Arcasoy 1972; Cavdar et al. 1977a Cavdar et al. , 1977b Arcasoy et al. 1978; Gonzalez et al. 1982; Severance et al. 1988; Ukaonu et al. 2003) .
The ingestion of dried clay minerals or a clay suspension is commonly used as a source of dietary elements, as a detoxifying agent, and as an allopathic treatment of gastrointestinal illnesses and acute and chronic diarrhoea (Carretero 2002) . For example, in Ghana, the iron, copper, calcium, zinc, and manganese consumed in clays were in the range of 2-15% of recommended dietary allowances (Hunter 1973) and it was concluded that moderate ingestion of clays lacking high cation exchange capacities could serve as a nutritional supplement for these essential elements. In the acidic environment of the stomach, the clay minerals could bind to positively charged toxins and serve as detoxifying agents to reduce bioavailability interfering with gastrointestinal absorption of the toxin (Hladik and Gueguen 1974; Johns and Duquette 1991; Phillips et al. 1995; Mahaney et al. 1996; Phillips 1999) . Over-the-counter pharmaceuticals that originally contained kaolinite, attapulgite, or clay-like substances (i.e. Kaopectate®) represent classic examples of the use of clay minerals by human populations to treat diarrhoea and intestinal illnesses (Vermeer and Ferrell 1985) and soothe gastrointestinal ailments. (Note: Kaopectate was reformulated in 2002 and now contains bismuth subsalicylate instead of kaolinite or attapulgite.) Kaolinite has many medically beneficial attributes primarily related to its ability to adsorb lipids, proteins, bacteria, and viruses (Steel and Anderson 1972; Wallace et al. 1975; Adamis and Timar 1980; Schiffenbauer and Stotzky 1982; Lipson and Stotzky 1983) .
Geology and geochemistry
The study of medicinal applications of minerals requires collaborative efforts by many specialists with diverse expertise and educational backgrounds, including, for example, geology, geochemistry, microbiology, environmental science, soils and agriculture, medicine, statistics, and pharmacology, to name a few. Understanding the interactions of natural minerals and microbial systems is an immense undertaking, so there is no limit to the efforts of diverse scientific disciplines in these arenas. Because of this, it is important to establish a basis of communication among the diverse scientific groups. Here we present some background and define some of the common terms used by geologists/mineralogists and clinical microbiologists in an attempt to alleviate misconceptions across disciplinary boundaries.
Clays and clay minerals
First and foremost, it is essential to define what clay is and how it differs from mud, soil, and minerals. In the field of geology, clay is a size-based term for very fine-grained minerals with an estimated spherical diameter of <2.0 μm and approximate density of 2.65 g/cm 3 as defined by Stokes' law (Jackson 1979; Moore and Reynolds 1997) . As gravel, sand, and silt are terms for sedimentary grain sizes, clay is the term for the finest fraction of sediments that all consist of accumulations of different minerals (e.g. quartz, feldspar, carbonates, etc.) and organic matter. Clay, when moistened with water, creates a mud-like consistency, comparable to that used in spas for pelotherapy. Soils often consist of many minerals, especially clay-sized minerals and organic matter (humus), as this medium must be able to support life by exchange of ions through water and gas that fills the spaces between the solid particles (Voroney 2006) . Mud is slurry of water and sediment dominated by clay and silt-sized particles. A mineral is a natural solid with a generally uniform composition and repeating internal crystalline order. When the crystalline domains are nanometres in scale, they are sometimes referred to as disordered or poorly crystalline. Clay minerals exhibit a wide range of order/disorder and crystallinity.
Most of the clay-sized fraction of sediments consists of clay minerals or phyllosilicates (defined below). Clay minerals are formed by weathering of other silicate minerals on and in the earth's crust, or they may precipitate directly from a solution. Minerals that form deep in the earth are likely to be unstable under the lower temperature and pressure conditions on earth's surface. When water and carbon dioxide from the atmosphere and from soil respiration interact with these minerals, they may dissolve often if the waters are acidic (carbonic acid) and the leached components precipitate as a variety of clay minerals (Giese and van Oss 2002) .
Bentonites
Most of the healing clays described in the literature (e.g. Carretero and Lagaly 2007 and references therein) are bentonites. However, bentonite is not a mineral but is a generic term for rocks derived from 'altered volcanic ash beds'. The ash is a layered sedimentary deposit that accumulates during volcanic eruptions. This ash produces mostly disordered solids but also glassy particles formed by rapid quenching (cooling) of magma when the liquid material is thrown into the atmosphere. The volcanic ash layers, when compacted and infiltrated with water, alter primarily to kaolinite in acidic environments, smectite in mildly alkaline (seawater) environments, or zeolites in highly alkaline environments (Bohor and Triplehorn 1993) . The mineralogical variations occur depending on the chemical characteristics of the volcanic glass and the local water chemistry (Christidis 1998) .
Smectite is a group of expandable clay minerals with a variety of structural and chemical differences that affect their surface charge and chemistry. Montmorillonite, commonly identified in 'healing clays', is one type of smectite. It has a structure of two tetrahedral sheets that sandwich a single octahedral sheet (Figure 1 ). Moore and Reynolds 1997) . Many elements can substitute into these various structural sites. In addition, water and organic compounds may be found in the interlayer sites and/or adsorbed on the edges and exterior surfaces of the crystal structure. Zeolites have properties similar to clays, but form tubes or cage-like structures that can also incorporate a variety of molecules and ions. Over time, if the bentonite is deeply buried and subjected to an increase in temperature, or if hot volcanic water percolates through the ash layer, the smectites will alter to form illites or other minerals that are stable under highertemperature conditions. The point here is that a bentonite usually does not consist of a single pure smectite, and each natural deposit is mineralogically variable.
Bentonite deposits are found worldwide wherever volcanic eruptions have taken place and preservation of the ash has exceeded erosion. Ten billion tons of bentonite are mined worldwide each year with about 35% being produced in the western USA (primarily Wyoming). The second largest producer of bentonite is Greece (Grim and Güven 1978) ; however, significant reserves are also found in many countries -Italy (Sardinia), India, China, and Australia, to name a few. Many of the clays used in pelotherapy come from these deposits and localities (Cara et al. 2000; Veniale et al. 2007) . 
Clay mineralogy
While natural clay samples contain a variety of minerals and organic compounds, clay minerals can often be isolated from the sample by selecting the finest-size fraction (<0.2 μm). It is very difficult to remove silica from the finest clay fractions, but other detrital minerals (feldspars, micas, carbonates, etc.) are usually concentrated in the coarser fractions (1-2 μm) (Jackson 1979; Moore and Reynolds 1997) .
Clay minerals are phyllosilicates (phyllo is Greek for 'leaf' or layers) consisting of layers of silicates arranged in tetrahedral and octahedral sheets (Figure 1 ). The clay silicate layers consist of sheets containing hexagonal rings of SiO 4 (silicate tetrahedra) stacked on octahedral sheets containing primarily Al, Mg, and/or Fe bound to two planes of closest packed oxygen atoms and/or hydroxyl groups. The edge-sharing octahedra may be filled with two trivalent (di-octahedral) or three divalent (tri-octahedral) cations for a total charge of +6 (Giese and van Oss 2002) . This charge is partially balanced by the −2 charge on oxygens, but the total charge balance depends on the structural arrangement and precise elemental substitutions within the silicate framework.
Kaolinite (the predominant mineral employed for making porcelain) and its polymorphs are 1:1 clay minerals, i.e. they have layers consisting of one tetrahedral sheet and one octahedral sheet. Smectite is one example of 2:1 clay minerals with layers containing an octahedral sheet sandwiched between two tetrahedral sheets ( Figure 1 ). The stack of two tetrahedral sheets to one octahedral sheet has an interlayer with water, cations, and molecules of highly variable chemical composition. Layers of the 2:1 clay minerals may be stacked in a variety of orientations and held together by electrostatic and van der Waals forces (Brindley and Brown 1980; Moore and Reynolds 1997) . When trivalent ions (e.g. Al 3+ ) substitute for tetravalent Si 4+ in the tetrahedral sheets, or divalent ions (Fe 2+ ) replace Al 3+ in the octahedral sheets, the basal surface (bottom plane of the tetrahedral sheets) develops a net negative charge. The magnitude and distribution of this charge can vary depending on where the substitutions take place (Güven and Pollastro 1992; Johnston 1996) . Smectites are the most common alteration product of bentonites, and many varieties of smectite are present in the antibacterial clays. Cations are attracted to the negative surface of the silicate sheets, whereas anions are attracted to the positively charged sites where bonding takes place at the edges of the crystalline structure (Moore and Reynolds 1997) . If this region collapses (water is removed) due to a high surface charge attracting cations (primarily K + ) to interlayer sites, it forms an illite. Chlorite is another group of layered silicates but with hydroxide sheets (e.g. MgOH 3 ) between the 2:1 silicate layers, and are known as 2:1:1 minerals. Giese and van Oss (2002) present excellent diagrams of the crystallography of the major classes of clay minerals. Most natural clay samples contain mixtures of these four major groups of phyllosilicates: smectite, illite, kaolinite, and chlorite. Table 1 summarizes the basic mineralogical classification of phyllosilicates. Within the 2:1 clays, the layer charge (interlayer cation occupancy) is used to distinguish the major clay sub-categories. Nonetheless, there are vast chemical substitutions and structural rearrangements in clay minerals that result in the wide variety found in nature.
Crystal growth and chemical variability
The growth of clay crystals and changes that may occur in their chemistry and structure are complex (see reviews in Altaner and Ylagan 1997; Srodon 1999) . However, it has been shown for sedimentary environments that clay minerals precipitate as small particles (<10 nm) and grow in diameter over time as water provides a continuous supply of components or 'building blocks' to the structure (Nadeau et al. 1984; Eberl et al. 1998) . The crystallite size distribution of clay minerals in most natural samples is log-normal, meaning there are more small crystals than large crystals (Eberl et al. 2002) . This distribution has been shown to result from the stunted growth of a large number of nucleated crystals from which a limited number of the clay crystallites continue to grow. Clay crystals can grow in a variety of morphologies depending on the temperatures and pressures of their geologic environment. At low temperatures (∼50°C), the crystallites tend to be irregular flakes. As temperature increases, rectangular laths may be found, and finally hexagonal plates may form at >100°C (Inoue et al. 1988; Lanson and Champion 1991) . The crystallite growth usually incorporates other dissolved elements into the clay structure; therefore, a change in the water chemistry over time may be recorded in different-sized crystals of clay (Clauer et al. 1997; Srodon 1999; Williams and Hervig 2006) .
Medicinal uses of clays
Most uses and research emphasis on healing clays have focused on the physical characteristics of clay minerals that benefit digestion or protect and cleanse the skin (Carretero 2002) . The adsorptive and absorptive properties of clay minerals have historically been the driving force behind the traditional use of healing and therapeutic clays. Initially, negatively charged interlayer sites of clays will absorb positively charged substances to their extensive surface area. Over time, many clay minerals may absorb substances in between the stacked silicate layers of the mineral, allowing for expansion and swelling or contraction. While the physical adsorption of water and organic matter is the most common attribute of healing clays, the geochemical mechanisms controlling antibacterial properties of clays have received significantly less attention.
It is well known that metallic ions, such as silver, copper, and zinc, have strong inhibitory and bactericidal effects on a broad spectrum of bacteria (Berger et al. 1976; Domek et al. 1984; Gordon et al. 1994) . Various forms of silver ions have been used to treat burn wound infections, osteomyelitis, urinary tract infections, and central venous catheter infections (Fox 1968; Fox and Modak 1974; Becker and Spadaro 1978;  Liedberg and Lundeberg 1990; Jansen et al. 1994; Davenport and Keeley 2005) . In low concentrations (4 μg/ml), silver ions produced inhibitory and bactericidal effects with no obvious toxic effect on human blood cells (Berger et al. 1976) . Although required by most living organisms at low concentrations, elevated levels of copper can inhibit the growth of some micro-organisms and exhibit bactericidal activity (Domek et al. 1984; Gordon et al. 1994) . The use of copper-coated products or copper alloys has been proposed for surfaces exposed to human contact to reduce the transmission of infectious microbial agents. Other metallic oxides, including zinc oxide, magnesium oxide, and calcium oxide, have antibacterial activity with demonstrated effectiveness against Escherichia coli and Staphylococcus aureus (Sawai 2003) . The nanometer particle size of these oxides, as well as of titanium and silicon dioxide (Yamamoto et al. 2000; Yamamoto 2001; Adams et al. 2006) , has proved to be important for antibacterial activity. Zinc oxide has been used in a variety of dental composites to treat or prevent dental caries and as an endodontic sealer (Turkheim 1955; Moorer and Genet 1982; Siqueira and Goncalves 1996) . Nonetheless, the antibacterial mechanism has not been identified. The high cation exchange capacity of different clay minerals has been targeted in the creation of inorganic antibacterial materials. Synthetic antibacterial clay minerals are prepared by exchanging their native ions with known antibacterial ions such as Ag (Ohashi 1993; Ohashi et al. 1998; Marini et al. 2007) , the rationale being that the novel exchanged ions will be gradually released from the synthetic clay for long-term antibacterial effectiveness. Thus far, silver-loaded clays have been pursued more aggressively than other antibacterial chemical ion options, although copper-loaded mineral substrates have been recently investigated (Gant et al. 2007) .
The mineral group of zeolites also has vast adsorptive and absorptive capabilities through a rigid, porous, three-dimensional channel or tube in their basic cryalline structure. Zeolites are compositionally similar to clay minerals and also have a high cation exchange capacity (Baerlocher et al. 2007) . With strong affinity for oxidized silver ions (Ag + ), up to 40% (w/w), silver-exchanged zeolites have demonstrated antibacterial effectiveness against aerobic and anaerobic Gram-negative and Gram-positive bacterial pathogens, including Pseudomonas aeruginosa, Porphyromonas gingivalis, Prevotella intermedia, S. aureus, Streptococcus mutans, and Streptococcus sanguinis, and have been used in various dental applications (Matsuura et al. 1997; Hotta et al. 1998; Kawahara et al. 2000) . Another study investigated the mechanism of action of silver-exchanged zeolites and determined that physical contact with the bacterial cell, silver transfer into the cell, and/or the generation of reactive oxygen species attributed to the bactericidal activity of silver zeolites (Matsumura et al. 2003) . However, while these inorganic products have antibacterial activity and low toxicity, issues related to the reduction of silver ions to elemental silver and subsequent loss of antibacterial effectiveness could be problematic (Li et al. 2002) . Therefore, an oxidized form of Ag appears to be important for bactericidal activity of silver-exchanged zeolites.
Vermiculite is another clay mineral that has been targeted for medicinal uses. Vermiculite is a smectite-like mineral, but with a high layer charge, thereby with a high attraction for cations (Mathieson and Walker 1954; Mathieson 1958) . As an alternative to silver, it is speculated that copper-loaded vermiculite could offer reduced costs, improved stability, and better antifungal activity (Li et al. 2002) . As demonstrated by antimicrobial testing, a copper-exchanged vermiculite (containing 5.5% Cu 2+ ), as well as 200°C-and 400°C-heated copper-exchanged vermiculite, inhibited the growth of E. coli (Li et al. 2002) .
Natural antibacterial clays
Unlike the synthetic clays and chemical manipulations of clay minerals manufactured to kill certain types of environmental and clinical bacteria, we focus now on natural, untreated clay minerals that are effective at killing a broad spectrum of human pathogens. The detailed results have been published elsewhere Williams et al. 2008) , but herein we outline the approach we use to evaluate the antibacterial activity of clays. Figure 2 schematically summarizes our approach to investigating the antibacterial properties of natural clays. We evaluated the effect of various clays and clay minerals on a broad spectrum of bacteria and determined whether the bactericidal effect was via a physical or chemical attack on the various pathogens. Again, our overarching goal is to understand how clay minerals kill bacteria in order to create new topical treatments for antibiotic-resistant skin infections and for large, necrotic skin ulcers. If we can identify the mechanism by which natural clay minerals kill a wide range of bacterial species, then it is possible that either natural clay deposits could be located and made available as an inexpensive treatment modality for topical infections or that materials with similar properties could be designed to provide a safe alternative to current antibiotics and antimicrobials.
Clinical observations of natural clays healing patients with Buruli ulcer
Within the past decade, the incidence of Buruli ulcer has dramatically increased in several countries in sub-Saharan Africa, Australia, Asia, Mexico, and Peru, leading the WHO to declare this disease a global health threat in (WHO 2004 . Despite being the third most common mycobacterial disease in immunocompetent humans after tuberculosis and leprosy (Weir 2002) , Buruli ulcer, considered a 'neglected tropical disease' by the WHO, does not garner the attention given to other infectious diseases. Although the exact prevalence and burden of the disease are difficult to determine, Buruli ulcer is endemic in central and western Africa with more than 40,000 Buruli ulcer cases recorded in the African countries of Côte d'Ivoire, Ghana, and Benin from 1978 to 2006 and some villages reporting rates as high as 16-22% (Amofah et al. 1993; Marston et al. 1995; WHO 2007) . The WHO estimates that the incidence of Buruli ulcer will surpass that of leprosy and could become more problematic than tuberculosis in some African regions (van der Werf et al. 1999; WHO 2007) .
M. ulcerans is a slow-growing environmental mycobacterium with an unknown source or natural reservoir (Dobos et al. 1999) . Human transmission is believed to occur (Portaels and Meyers 1999; Weir 2002) . Most individuals infected with M. ulcerans initially develop a small, painless, preulcerative skin nodule or plaques with larger areas of indurated skin and oedema (van der Werf et al. 1999) . As the disease progresses over 1-2 months, the infected skin will begin to ulcerate with characteristic necrosis of the subcutaneous fatty tissues, deeply undermined edges, and vascular blockage. These necrotic ulcers can lead to very extensive skin loss, damage to nerves, blood vessels, and appendages, and deformity and disability, particularly in children (van der Werf et al. 1999; Weir 2002) . One study reported that 26% of patients with healed Buruli ulcers suffered from chronic functional disability (Marston et al. 1995) .
Currently, treatment of Buruli ulcer, depending on the size of the lesion, includes antibiotic therapy and/or surgical excision of the ulcerative lesion. Thirty years ago, variable successes in uncontrolled trials were demonstrated with heat treatment and hyperbaric oxygen treatment (Meyers et al. 1974; Krieg et al. 1975) . However, the impracticality and costs of these treatments abrogate their usefulness in endemic and underprivileged populations. Phillips et al. (2004) used topical aqueous creams releasing nitrogen oxides to decrease the size of ulcers with minimal adverse side effects. Recently, Chauty et al. (2007) determined that a combination of rifampin (taken orally) and streptomycin (injected intramuscularly) successfully treated 47% of the cases and was more effective against small Buruli ulcer lesions (<5 cm in diameter). In addition, rifampin and streptomycin treatment converted early M. ulcerans lesions (nodules and plaques) from culture positive to culture negative (Etuaful et al. 2005) . According to WHO guidelines (2004) , combined use of streptomycin and rifampin is the recommended treatment of early Buruli ulcer lesions (nodules, papules, plaques, and ulcers less than 5 cm in diameter). For treatment of ulcerative lesions greater than 5 cm in diameter, combined antibiotic therapy for 4 weeks, followed by surgical excision of the lesion and another 4 weeks of antibiotic treatment, is recommended (WHO 2004). While surgery is standard treatment for large ulcerative lesions, antibiotic therapy reduces the extent of surgical excision and infection recurrence (WHO 2004) . Since surgical treatment is often not available or practical in rural, endemic regions and possibly subjects patients to other infections, development of an effective and affordable drug treatment and new treatment modalities is a research priority for the control of Buruli ulcer (WHO 2007) .
The treatment of Buruli ulcer by Line Brunet de Courssou employed two clay samples provided by different suppliers of 'French green clay' (Brunet de Courssou 2002). These clays are thought to be altered volcanic ash deposits from central France. The dry clay is mixed with water and applied as a paste directly to the ulcerated lesions and extended healthy skin of infected patients. The course of treatment is to remove and renew the clay packs at least once a day. Within days of initiating treatment with clay poultices, the therapeutic properties of the clay minerals were demonstrated, with the initiation of rapid, non-surgical debridement of the destroyed tissue. Extended treatment with the clay poultices resulted in continued debridement of the ulcer, regeneration of healthy tissue, and wound healing. After several months of daily clay applications, the Buruli ulcer wounds healed with soft, supple scarring, allowing return of normal motor function (Brunet de Courssou 2002; Williams et al. 2004 ). These observations are highly relevant since antibiotic treatment is only effective for small early lesions (nodules and plaques <5 cm in diameter) and has generally been unsuccessful as the sole treatment for larger, ulcerative forms of Buruli ulcer disease (van der Werf et al. 1999; Chauty et al. 2007) .
Microbiology introduction
The mechanism by which natural clay minerals kill bacteria should be understood in order to search for the least expensive cure modalities and specifically to maximize effective antibacterial agents. Therefore, we have been investigating the antibacterial properties of several different natural clays, including the two French clays used by Brunet de Courssou, referred to as CsAr02 and CsAg02. We have tested these clays on a series of Gram-negative, Gram-positive, and mycobacterial pathogens using the technique of broth culture susceptibility testing. The cell envelopes of these bacteria greatly differ and these differences could influence their vulnerability and response to inorganic materials. Compositionally, the three groups of bacteria are similar with a cytoplasmic membrane and a rigid polysaccharidepeptide cell wall called peptidoglycan (Figure 3) . However, the Gram-positive cell wall is considerably thicker than the Gram-negative cell wall. The thinner Gram-negative cell wall is covered by an outer membrane, composed of phospholipids and lipopolysaccharides, and has a periplasmic space between the cell membrane and the outer membrane ( Figure 3) . Genetically, mycobacteria are Gram-positive bacteria. However, the mycobacterial cell envelope is more structurally similar to that of Gram-negative bacteria. In addition to having a thinner cell wall than traditional Gram-positive bacteria, the mycobacterial peptidoglycan layer is linked to a waxy lipid coating by an arabinogalactan layer. This outer waxy layer is predominantly composed of special lipids called mycolic acids and glycolipids, e.g. lipoarabinomannan (Figure 3 ). The different cell types have distinct cell envelopes that play a significant role in the effectiveness of various antimicrobial agents.
Antimicrobial agents
The use of antibiotics and chemotherapeutic agents during the past century represents one of the greatest advances in human health and has led to a remarkable reduction of morbidity and mortality related to bacterial infections. In modern medicine, antibacterial, antimicrobial, and chemotherapeutic agents are terms used to describe chemical agents effective at treating infectious diseases. Most of these agents are antibiotics, which by definition are low-molecular-weight by-products of micro-organisms that kill or inhibit the growth of other and susceptible micro-organisms. The term 'antibiotic' is often incorrectly used to describe antibacterial or chemotherapeutic agents that are synthetically manufactured or modified by chemical processes, independent of microbial activity, to optimize their activity. Although the antibacterial clay minerals discussed herein are natural substances, they are not produced by micro-organisms and are not considered antibiotics. In an ideal situation, antimicrobial agents disrupt microbial processes or structures that largely differ from those of the host. The majority of known antimicrobials function by affecting cell wall synthesis, inhibiting protein and nucleic acid synthesis, disrupting membrane structure and function, and inhibiting the key enzymes essential for various microbial metabolic pathways.
Chemotherapeutic or antibacterial agents can be either bacteriostatic or bactericidal. A bacteriostatic agent reversibly inhibits microbial growth and micro-organisms will resume growth upon removal of the bacteriostatic agent. Since bacteriostatic antimicrobials do not kill the bacteria, elimination of the infection is dependent on the host's resistance and immune response. When administered at sufficient levels, a bactericidal agent kills the targeted bacterial pathogen. However, it is important to realize that the effectiveness of the antimicrobial is largely dependent on the targeted bacterium. An antimicrobial agent that is bactericidal for one particular bacterial species may be bacteriostatic for another. Moreover, various antibacterial agents vary considerably in their range of effectiveness. A narrowspectrum antibacterial is effective against a limited number of pathogens, usually Grampositive or Gram-negative bacteria, but not both. A broad-spectrum antimicrobial is generally effective at destroying or inhibiting the growth of a wide range of Gram-positive and Gram-negative bacteria.
Effects of two natural clay minerals on bacterial growth
The extensive use of antibiotics has led to an increase in antibiotic resistance in many pathogenic and clinically relevant bacteria, including Mycobacterium tuberculosis, S. aureus, Enterococcus faecalis, and Streptococcus pneumoniae (Menichetti 2005; Shah 2005; Sharma et al. 2005; Zetola et al. 2005) . Therefore, modern and innovative research approaches are needed to identify and generate new antimicrobials for treating infections that are resistant to existing antibiotics or for which there is no known effective therapeutic agent. Using antibiotic-sensitive and antibiotic-resistant bacterial strains obtained from the American Type Culture Collection (ATCC) and a local diagnostic laboratory, we have been investigating the antibacterial properties of the two clays, CsAg02 and CsAr02, used to treat Buruli ulcer patients. The CsAr02 mineral promoted or had no effect on bacterial growth . In contrast, CsAg02 exhibits an extraordinary ability to kill pathogenic E. coli, Salmonella enterica serovar Typhimurium, P. aeruginosa, ESBL E. coli (which is resistant to 11 antibiotics), and Mycobacterium marinum (a species genetically closely related to M. ulcerans, which also causes a cutaneous infection) as well as inhibit the growth of pathogenic S. aureus, penicillin-resistant S. aureus (PRSA), and methicillin-resistant S. aureus (MRSA) . During the course of her observations, Brunet de Courssou suggested that the CsAg02 clay was not as effective in killing M. ulcerans as the CsAr02 clay (although this was not demonstrated microbiologically), but was more suited for promoting skin granulation after the mycobacteria were killed (Brunet de Courssou 2002) . The scientific basis of the therapeutic differences or the healing characteristics of these two clay minerals is still under investigation.
Broad-spectrum in vitro susceptibility testing
In vitro broad-spectrum antimicrobial activities of clay minerals were tested against bacterial strains that are recommended by the Clinical and Laboratory Standards Institute (CLSI; formerly NCCLS) as quality control strains for laboratory testing of antimicrobials (NCCLS 2004) . Bacteria are grown overnight in common laboratory liquid media and diluted with fresh medium to achieve an approximate initial density of ∼10 7 bacteria per millilitre. Adjustment of each bacterial inoculum is performed using a spectrophotometer since the experimental micro-organisms exhibit varying replication times in liquid media. To confirm the initial bacterial counts, serially diluted bacterial cultures are plated onto appropriate agar plates and colony-forming units are counted after incubation at 37°C. Before use in any susceptibility testing, all clay mineral samples are sterilized by autoclaving at 121°C (at 15 psi) for 1 h to assure removal of airborne, inherent, or contaminating microbes. To achieve a consistency similar to the hydrated clay poultices used to treat Buruli ulcer patients, 200 mg of clay minerals is added to 400 μl of the initial inoculum of bacteria in an appropriate growth medium. After the addition of clay minerals, the bacteriaclay mineral mixtures are incubated in capped test tubes at 37°C in ambient air for 24 h (NCCLS 2004) with constant rotary agitation to ensure contact with the clay minerals and to prevent sedimentation. Positive controls for growth of bacteria in the absence of clay minerals are included in each series of independent experiments. To ensure that the clay samples were sterilized after autoclaving and maintained sterilization during storage, negative control growth experiments with clay minerals in liquid media are performed several times throughout the course of the study. These conditions revealed the complete killing of E. coli, Salmonella Typhimurium, P. aeruginosa, and M. marinum by CsAg02 .
Given that the clays were hydrated with water for treating Buruli ulcer lesions and are generally hydrated with water for therapeutic use, we have initiated 'use-derived' antibacterial testing of the clay minerals, whereby the clay and the bacteria are incubated together in a sterile, de-ionized water solution. After growth in a liquid medium, bacteria are washed twice and suspended (∼10 7 CFU) in 1 ml of sterile de-ionized water before the addition of clay minerals and subsequent incubation at 37°C. Depending on the type of clay, poultice consistencies used for therapeutic purposes are generally ratios of 1:2 or 1:3 (clay:water). To determine the effect of quantity, various amounts of the clays can be added to 1 ml aliquots of the aqueous bacterial suspension. Bacteria-clay mineral suspensions are incubated rotating at 37°C for 24 h, at which time serial dilutions of all samples are plated to determine bacterial viability. Minimal bactericidal concentration (MBC) is defined as the lowest concentration of a particular antibacterial agent that kills ≥99.9% of the bacterial population in a liquid medium.
Mineralogical and geochemical assessment of antibacterial clays
Initial testing of the two French green clays (in 2003) showed that only one of the clays (CsAg02) killed a non-pathogenic, laboratory strain of E. coli even though the two clays, CsAg02 and CsAr02, were very similar in general mineralogy with the dominant portion of the sample consisting of clay minerals as set out in Table 2 along with quartz, calcite, and feldspar (Williams et al. 2004) . Subsequent testing of CsAg02 and CsAr02 against a pathogenic strain of E. coli revealed similar results and their mineralogical compositions were very similar. The clay fraction was dominated by smectite, a group of expandable clay minerals and a common component of all of the antibacterial clays we have investigated. However, a substantial amount of illite is also present in the French clays. Notably, the illite-smectite crystals in the French clays are of extremely small size relative to natural illite and smectite reference materials from the Source Clays Repository (www.clays.org) at Purdue University (Figure 4 ).
Size fractionation of clay minerals
In order to eliminate the possibility that other mineral phases were responsible for killing the bacteria, we separated sequentially smaller size fractions of the mineral mixture using centrifugation (Jackson 1979) . Evaluating the antibacterial effect of the coarse-(1.0-2.0 μm), medium-(0.2-1.0 μm), and fine-(<0.2 μm) size fractions independently against E. coli allowed us to eliminate detrital minerals (quartz, carbonate, feldspar) from the clays as potential participants in the antibacterial effect. We found that only the finest fraction (<0.2 μm) was effective against E. coli, while the coarser fractions had no effect on bacterial growth Haydel et al. 2008) . Furthermore, X-ray diffraction analyses of the finest clay fraction confirmed that the coarser detrital mineral phases had been largely eliminated. Smectite dominated the <0.2 μm fraction. Figure 5 shows two different morphologies of crystals in the <0.2 μm fractions of the French clays. The antibacterial clay has crystals as small as 20 nm, and this enormous relative surface area controls the water chemistry when wet.
Others have shown that particle size affects antibacterial activity for various oxides (e.g. ZnO, MgO), such that bactericidal activity increases with decreasing particle size (to 0.1 μm) (Yamamoto 2001; Sawai 2003) . Adams et al. (2006) showed that nanoparticles of TiO, SiO, and ZnO are photosensitive, with light promoting the formation of reactive oxygen species. Further evaluation is needed to determine the potential role of oxides associated with the clay mineral surfaces in chemical reactions that could influence the survival of pathogens. One way to do this is to selectively chelate metal oxides out of the sample and evaluate the resulting antibacterial effect, or to remove hydroxyl and superoxide radicals before testing. Mössbauer spectroscopy is another useful tool for evaluating oxide versus clay mineral-metal bonds in clay samples (Stucki et al. 1996) . Next, we need to determine if the fine clay fraction was killing E. coli by a physical or chemical effect. Were the clays physically impeding a metabolic process of the bacteria by surface attractive forces, causing the clay to wrap around, penetrate, or otherwise destroy the cell walls? Or, was the clay producing a toxic chemical that precipitates on the cell walls or that enters the bacterial cell inducing cellular death? By inserting a dialysis tube filled with an antibacterial clay suspension into a bacterial population in liquid growth media, Metge et al. (2009) showed that the bacteria were killed without physically contacting the clay mineral surfaces. Given this observation, we leached the antibacterial clay with distilled, de-ionized water. Two grammes of the antibacterial clay were ultra-sonified (using a Braun micro-tip ultrasonic disaggregator) in 40 ml water, then shaken for 24 h to equilibrate. The clays were removed from suspension by centrifuging for 3 h at 20,000 rpm (SS-34 rotor). The leachate was then tested against bacteria. Compared to control samples of E. coli in distilled water, the clay leachate also killed E. coli. This evidence suggested that the antibacterial clay killed by providing a toxin. Nonetheless, after water leaching, the clay sample continued to kill E. coli. In fact, separation of the different size fractions of the clay also required multiple washings and centrifugation cycles in de-ionized water, which did not eliminate the bactericidal effects of the minerals. These results indicate that the antibacterial agent is not highly soluble.
Cation exchange of clay minerals
The next test was to evaluate if the antibacterial agent(s) could be removed by cation exchange. Ions and molecules can be bound to the interlayer surface of the expandable clays or adsorbed on the edges. Cation exchange is performed by soaking the clay fraction of interest in a concentrated (1 M) solution containing 'preferred cations' or ions with the best fit in ionic radius and charge for the interlayer exchange sites (Jackson 1979) . One can remove any chemical species that are not tightly bonded (fixed) in the clay structure. This is the commonly used procedure to determine the 'cation exchange capacity' of clay (Moore and Reynolds 1997) , but the process also removes ionic or molecular species that might be involved in the antibacterial mechanism. After cation exchange, we found that the smectite-rich clay samples (<0.2 μm fraction) no longer killed E. coli , indicating that the antibacterial agent is linked to ions that are presumably in the exchangeable sites of the clay. However, the cation exchange will also affect the surface energy of the clay mineral and may affect the pH of the clay surface (zero point of charge), so we attempted to evaluate these complicating factors.
Heating experiments
One common way to remove interlayer water and hydroxyl groups from clays is by progressive heating. In general, the clay becomes dehydrated, as the interlayer water is removed, by heating to 200°C. At 550°C or more (depending on chemical bonding), most iron-rich smectites dehydroxylate, meaning that all hydroxyl bonds in the octahedral layer are broken (Heller-Kallai and Rozensen 1980) . However, it is important to note that the temperature for dehydroxylation varies depending on the clay mineral structure and composition (Bish and Duffy 1990) . Upon heating to 900°C, the clay mineral structure is effectively destroyed, leaving only the oxide components.
Progressive heat treatments were applied to the French antibacterial clay in order to eliminate some of the possible bactericidal elements from consideration. Heating to 200°C (24 h in air) removes volatile elements in addition to water (including H, O, N, F, Cl, Br, and I) . Although it is important to consider how these elements are bound in the mineral structure, certainly their presence in the hydrated interlayer would be affected by temperatures leading to volatilization. Tests of the clay after heating to 200°C showed that it still killed E. coli Williams et al. 2008) . This heating step provides evidence that the antibacterial agent in the clay is not an inherent micro-organism, as they would certainly be killed at this temperature, even if the clay had previously physically protected them.
Heating to 550°C (24 h in air) showed significant oxidation of the French antibacterial clay as it turned from green to orange-red due to oxidation of Fe in the octahedral sites of the clay . However, the clay still killed E. coli . This high temperature would be expected to volatilize elements including S, P, and Hg if they were not tightly bound in the phyllosilicate structure. Furthermore, this step of the process verifies that the antibacterial agent is not an organic compound as they are certainly eliminated at this high temperature.
Heating to 900°C highly oxidized the French antibacterial clay (CsAg02), turning it a deep red; this caused the clay to lose its antibacterial effectiveness Williams et al. 2008) . The lost antibacterial effect could point to elements lost above 550°C as the active antibacterial agents; however, the highly oxidized state may alter the toxicity of remaining elements, or recrystallization may change the availability of elements that were bactericidal before heating. The major oxides of both clay samples, including Si, Al, Ca, Fe, Mg, Mn, and Ti, remain, but the clays lose their coherent crystalline structure. This temperature leaves many refractory elements in oxidized form, but those lost between 550°C and 900°C include Na, K, As, Se, Rb, Cd, and Cs. Table 3 compares the abundances of the refractory elements in the two French clays before heating.
The conclusion from this heating analysis is that the more volatile elements or compounds are not necessary for the antibacterial action displayed by this particular clay. The experiments do not conclusively identify a toxic substance, but are a method for eliminating some of the variables from consideration.
Chemical speciation
All of the tests and chemical manipulations of the French antibacterial clay (CsAg02) leave elemental components in abundances that are well below the minimal inhibitory concentrations (MICs) reported to be toxic to E. coli (Nies 1999; Dopson et al. 2003; Wackett et al. 2004 ) and other bacteria tested . However, MICs are usually tested at a neutral or near-neutral pH, which does not attest to the fact that the pH and oxidation state of the metals must also be considered. Metal speciation is critical to their bioavailability and the subsequent interaction with bacteria (Reeder and Schoonen 2006) . Therefore, in the future we aim to establish what chemical species are soluble under the pH and oxidation state buffered by the clay mineral surfaces in order to evaluate the element mobility of antibacterial clays (Tateo and Summa 2006) . The whole process of transferring elements from a clay surface through water to a cell membrane involves numerous chemical reactions and variables that can be affected not only by the source clay and water chemistry but also by the surface complexation of chemical species on the bacteria (Barrok et al. 2005) .
Additional considerations
Cellular processes important for metabolism, nutrient transport, movement, and cell division are localized at the cell membrane, which is the reactive surface controlling chemical accommodation, and may vary with environment (Konhauser 2007; Lalonde et al. 2008a Lalonde et al. , 2008b . The ability of a given bacterial species to modify its surface chemistry in order to adapt to various environmental stresses depends on the growth phase, regulatory net-works, metabolic pathways, and chemical variables in the environment (Warren and Ferris 1998; Lalonde et al. 2008a Lalonde et al. , 2008b . There are three general mechanisms by which bacteria can accommodate high concentrations of ions that may be toxic to the species: (1) the ions may be expelled from the cell by efflux (Nies and Silver 1995) , (2) the metal ions may complex into non-toxic molecules such as thiols (S-compounds) in the surrounding solution, or (3) the metal ions may be reduced to a less toxic oxidation state in the cell (Nies 1999) . Unwanted reduced metal ions usually are eliminated from cells by an efflux system. However, by application of antibacterial clay or its soluble compounds to the bacteria, there is the potential for precipitation of compounds that would inhibit efflux of toxins from bacteria. A geochemically induced gradient in pH or oxidation state, imposed by the presence of the antibacterial clay mineral, could clearly be damaging to the functions of even the most adaptive bacteria. Reactive oxygen species are another frontier for investigation of the possible inhibitors active against bacteria. Fenton-mediated reactions, for example, drive the oxidation of mineral-bound Fe 2+ to generate hydroxyl radicals (Fenton 1894; Cohn et al. 2006; Schoonen et al. 2006 ) that can damage cells. Furthermore, during active infections, it is important to consider the complexity of host-pathogen interactions, largely influenced by in vivo chemistry, in addition to the chemical interactions identified in vitro (Sahai and Schoonen 2006 ). If we can integrate analytical protocols in the study of bacterial metabolism, adaptation, and pathogenesis with methods of mineral and chemical manipulation and characterization (see reviews in Banfield and Nealson 1997; Reeder and Schoonen 2006) , the forward motion of identifying new antibacterial agents or processes will be much better served.
Concluding remarks
In this era when bacteria are developing antibiotic resistance to existing pharmacological agents, the potential for discovery of new broad-spectrum antibacterial agents, such as natural clay minerals, to combat pathogenic bacteria would be particularly advantageous. Analysis of the chemical interaction occurring at the clay mineral-bacterial interface is being explored and will be pertinent in understanding the mechanism by which the clay minerals can inhibit bacterial growth. Initial investigations indicate that particular natural clay minerals can have striking and very specific effects on microbial populations. These effects can range from enhanced microbial growth to complete growth inhibition, and these opposite effects can occur with clay minerals of similar structure and bulk crystal chemistries. The key antibacterial agent is likely a trace element or transition metal group stabilized by the ability of particular clay minerals to buffer the aqueous speciation of those elements involved in the antibacterial process.
During the past 25 years, approximately 70% of newly discovered drugs introduced in the USA have been derived from natural products (Newman and Cragg 2007) . Topical treatments by clay minerals have considerable advantages over surgery or generalized antibiotic therapy due to the practical simplicity of the application in the area specifically affected, as compared to ingestion of drugs with potential side effects. The broad-reaching impacts of antimicrobial mineral research with applications in topical antimicrobial dressings, wound care management, personal care, and animal care markets are obvious. The discovery that natural minerals harbour antibacterial properties should provide impetus for exploring terrestrial sources for novel therapeutic compounds. Often natural products, such as clays, which are heterogeneous in chemical composition and physical character, are rejected as therapeutic agents by regulatory agencies. Nevertheless, in comparison to organic antimicrobial agents, inorganic minerals are likely to be considerably more stable and heat-resistant, making the development and use of inorganic antimicrobial agents particularly advantageous. Combining the availability of natural, potentially bioactive resources with powerful combinatorial chemistry optimization methodologies could result in the development of new antibacterial agents to fight existing antibiotic-resistant infections and diseases for which there are no known therapeutic agents, such as advanced M. ulcerans infections.
Clearly, understanding the antibacterial mechanism of natural clay is complex, and it is possible that no single mechanism or set of reaction pathways is uniquely responsible for the observed bactericidal activity. Our future work will focus on identifying general themes displayed by the interaction presented herein between problematical human pathogens (e.g. MRSA) and the natural clay minerals that have now been shown to kill such bacteria . To progress towards understanding how antibacterial clays can be effective for treating bacterial infections will require integrated mineralogical, chemical, and microbial studies
The work of Konhauser (2007) and his co-workers describe novel methods for studying environmental bacteria and their chemical interactions with minerals in sedimentary environments. Similar methods must be employed in clinical microbiological research on antibacterial minerals. For example, the forces of attraction between bacterial species and mineral surfaces (Cail and Hochella 2005) , the formation of membrane vesicles and other mechanisms for accommodating environmental stresses (Mashburn-Warren et al. 2008) , and the response of various bacteria to oxidative and reductive variables, in addition to pH, should be evaluated. This new focus in medical geo-microbiology should grow exponentially, just as environmental microbiology has developed exponentially over the last three decades (Konhauser 2007) . Although the use of clays in human health has been promoted empirically and traditionally, perhaps since the beginning of mankind, our knowledge of natural mineral impacts on human pathogens is in its infancy. New technology for determining physical and chemical interactions in situ on the nanoscale will provide the keys to opening these doors (Skinner 1997) .
